智飞生物：CA111注射液进入Ⅰ期临床试验。

Group 1 - The core point of the article is that Zhifei Biological has initiated Phase I clinical trials for its CA111 injection [1] Group 2 - The CA111 injection is a significant development in the company's pipeline, indicating progress in its research and development efforts [1]